Glioblastoma microenvironment-from biology to therapy.
Renee D ReadZoe M TappPrajwal RajappaDolores HambardzumyanPublished in: Genes & development (2024)
Glioblastoma (GBM) is the most aggressive primary brain cancer. These tumors exhibit high intertumoral and intratumoral heterogeneity in neoplastic and nonneoplastic compartments, low lymphocyte infiltration, and high abundance of myeloid subsets that together create a highly protumorigenic immunosuppressive microenvironment. Moreover, heterogeneous GBM cells infiltrate adjacent brain tissue, remodeling the neural microenvironment to foster tumor electrochemical coupling with neurons and metabolic coupling with nonneoplastic astrocytes, thereby driving growth. Here, we review heterogeneity in the GBM microenvironment and its role in low-to-high-grade glioma transition, concluding with a discussion of the challenges of therapeutically targeting the tumor microenvironment and outlining future research opportunities.
Keyphrases
- stem cells
- high grade
- resting state
- induced apoptosis
- white matter
- single cell
- acute myeloid leukemia
- room temperature
- bone marrow
- gold nanoparticles
- dendritic cells
- spinal cord
- functional connectivity
- cell cycle arrest
- squamous cell carcinoma
- ionic liquid
- mass spectrometry
- multiple sclerosis
- current status
- immune response
- endoplasmic reticulum stress
- mesenchymal stem cells
- subarachnoid hemorrhage
- cell therapy
- label free
- childhood cancer